Raphael Pharmaceutical IncOTCQB:RAPH
- LAST PRICE0.2600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.2300/ 50
- Ask / Lots0.7000/ 10
- Open / Previous Close--- / 0.2600
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Raphael Pharmaceutical Inc | 4.9M | -4.9x | --- |
Purple Biotech Ltd | 4.8M | 0.0x | --- |
Bionomics Ltd | 4.8M | 0.0x | --- |
Hepion Pharmaceuticals Inc | 4.8M | -0.2x | --- |
Aptevo Therapeutics Inc | 4.9M | 0.0x | --- |
Check Cap Ltd | 4.7M | -0.3x | --- |
Company Information
Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company. The Company is focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The Company is in pre-clinical development stage for its lead product candidate, rheumatoid arthritis (RA), for the treatment of RA. In addition, the Company is also developing a pharmaceutical drug product for the treatment of hyperinflammatory syndrome inflammation related to COVID-19. The Company’s discovery platform focuses the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient (API), for its RA product candidate and COVID-19 product candidate.
Contact Information
- Headquarters
- SUITE 105 - 5348 VEGAS DR.LAS VEGAS, NV, United States 89108
- Phone
- 702-442-1166
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Shlomi Pilo
- Chief Financial Officer, Director
- Guy Ofir
- Chief Technology Officer, Director
- Igal Louria-hayon
- Independent Director
- Yehuda Eliya
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 18.7M |
Raphael Pharmaceutical Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.05 |
Book Value | $0.01 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
